Search results for " tachycardia"

showing 10 items of 75 documents

Prophylactic Implantable Cardioverter Defibrillator Placement in a Sporadic Desmin Related Myopathy and Cardiomyopathy

2004

Desminopathy is a neuromuscular disorder associated with the accumulation of the protein desmin. This article reports a case of a man with a mutation in the desmin gene suffering from cardiomyopathy and skeletal myopathy. This patient underwent implantable cardioverter defibrillator (ICD) implantation for prognostic considerations and subsequently developed a sustained ventricular tachycardia (SVT). While nonsustained VTs (NSVT) have previously been reported, this is the first time that a SVT could be seen in a patient with this disease.

Malemedicine.medical_specialtyAdolescentmedicine.medical_treatmentCardiomyopathyDiseaseDesminInternal medicineHumansMedicineDESMIN-RELATED MYOPATHYbusiness.industryImplantable Cardioverter-Defibrillator PlacementGeneral MedicineImplantable cardioverter-defibrillatormedicine.diseaseSkeletal myopathyDefibrillators ImplantableSustained ventricular tachycardiaMutationTachycardia VentricularCardiologyDesminCardiomyopathiesCardiology and Cardiovascular MedicinebusinessMyopathies Structural CongenitalPacing and Clinical Electrophysiology
researchProduct

Reproducibility of electrocardiographic findings in patients with suspected reflex neurally-mediated syncope

2008

The reproducibility of electrocardiographic (ECG) recordings in syncopal recurrences and the diagnostic role of nonsyncopal arrhythmias are not well known. The objective of this study was to analyse the reproducibility of the ECG findings recorded with implantable loop recorders in 41 patients with suspected neurally-mediated syncope who were included in the International Study on Syncope of Uncertain Origin-2 study and that had > or =2 events recorded by implantable loop recorders. In these patients, the electrocardiogram obtained with the first documented syncope (index syncope) was compared with other recorded events. Twenty-two patients had > or =2 syncopes, and their electrocardiograms…

Malemedicine.medical_specialtySocio-culturaleNeurological disorderVentricular tachycardiaElectrocardiographyInternal medicinemedicineSyncope VasovagalHumansSinus rhythmProspective Studiescardiovascular diseasesAsystoleProspective cohort studymedicine.diagnostic_testbiologybusiness.industrySyncope (genus)Reproducibility of ResultsMiddle Agedmedicine.diseasebiology.organism_classificationElectrocardiographic FindingAnesthesiaCardiologycardiovascular systemFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiography
researchProduct

Effects of alterations in sympathetic nervous activity on the severity of reperfusion-induced arrhythmias in anaesthetised rats.

1987

The effects of a number of interventions influencing sympathetic nervous activity on the severity of coronary artery reperfusion-induced arrhythmias in anaesthetised rats have been examined. Noradrenaline (0.1 microgram kg-1 min-1) reduced the mortality that usually occurred as a consequence of ventricular fibrillation. Isoprenaline (5 micrograms kg-1) did not significantly affect the severity of reperfusion-induced arrhythmias, although arrhythmias occurring during the 5-min period of ischaemia were exacerbated. The alpha-adrenoceptor antagonist nicergoline (0.25 and 0.5 mg kg-1 min-1) markedly suppressed both the ventricular tachycardia and fibrillation occurring upon release of the occlu…

Malemedicine.medical_specialtySympathetic Nervous SystemAdrenergic beta-AntagonistsThyroid GlandVentricular tachycardiaNorepinephrineInternal medicineIsoprenalineCoronary CirculationmedicinePrazosinAnimalsAnesthesiacardiovascular diseasesAdrenergic alpha-AntagonistsPharmacologyFibrillationbusiness.industryIsoproterenolSympathectomy ChemicalArrhythmias CardiacRats Inbred StrainsReserpineAtenololmedicine.diseaseRatsVentricular fibrillationcardiovascular systemCatecholamineCardiologymedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugJournal of cardiovascular pharmacology
researchProduct

Sudden cardiac death while wearing a Holter monitor

1991

The Holter tapes of 61 patients (46 men, mean age +/- standard deviation 65 +/- 11 years) with sudden cardiac death while being monitored were analyzed. Thirty-eight patients were known to have coronary artery disease, 5 had cardiomyopathy, and 7 had aortic valve disease. Etiology remained unknown in 11 patients. Mean New York Heart Association functional class was 2.5 +/- 0.7. Thirty patients had received antiarrhythmic drugs and 32 had received digitalis. Sudden death occurred at rest in 73%. In the hours before death, repetitive ventricular arrhythmias were found in 50 patients (82%), with atrial fibrillation in 34%. Patients with bradyarrhythmic death (18%) had less complex ventricular …

Malemedicine.medical_specialtyTime FactorsCardiomyopathyTorsades de pointes030204 cardiovascular system & hematologyVentricular tachycardiaSudden deathSudden cardiac deathDeath Sudden03 medical and health sciences0302 clinical medicineHeart RateTachycardiaInternal medicineAtrial FibrillationmedicineHumanscardiovascular diseases030212 general & internal medicineAgedmedicine.diagnostic_testbusiness.industryArrhythmias CardiacSignal Processing Computer-AssistedAtrial fibrillationmedicine.diseasePrimary ventricular fibrillationHeart Arrest3. Good healthAnesthesiaElectrocardiography Ambulatorycardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyThe American Journal of Cardiology
researchProduct

Impact of biatrial defragmentation in patients with paroxysmal atrial fibrillation: Results from a randomized prospective study

2014

Single procedure success rates of pulmonary vein isolation (PVI) in patients with paroxysmal atrial fibrillation (PAF) are still unsatisfactory. In patients with persistent atrial fibrillation (AF), ablation of complex fractionated atrial electrograms (CFAEs) after PVI results in improved outcomes.We aimed to investigate if PAF-patients with intraprocedurally sustained AF after PVI might benefit from additional CFAE ablation.A total of 1134 consecutive patients underwent a first catheter ablation procedure of PAF between June 2008 and December 2012. In most patients, AF was either not inducible or terminated during PVI. In 68 patients (6%), AF sustained after successful PVI. These patients …

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentElectric CountershockCatheter ablationCardioversionPulmonary veinHeart Conduction SystemHeart RatePhysiology (medical)Internal medicineAtrial FibrillationmedicineHumansSinus rhythmProspective StudiesTachycardia ParoxysmalProspective cohort studyAtrial tachycardiabusiness.industryAtrial fibrillationMiddle Agedmedicine.diseaseAblationTreatment OutcomePulmonary VeinsAnesthesiaCatheter AblationCardiologyFemalemedicine.symptomElectrophysiologic Techniques CardiacCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesHeart Rhythm
researchProduct

5-Year Outcome of Pulmonary Vein Isolation by Loss of Pace Capture on the Ablation Line Versus Electrical Circumferential Pulmonary Vein Isolation

2017

This study sought to compare long-term arrhythmia-free survival between electrical circumferential pulmonary vein isolation (PVI) and PVI with the endpoint of unexcitability along the ablation line.PVI is the standard ablation strategy of paroxysmal atrial fibrillation, although arrhythmia recurrence in long-term follow-up (FU) is high. The endpoint of unexcitability along the ablation line results in decreased arrhythmia recurrence compared to electrical PVI in 1-year FU.Seventy-four consecutive patients (age 62.5 ± 10.6 years; 70.3% male) with de novo paroxysmal atrial fibrillation who were initially included in our randomized trial and underwent catheter ablation at our institution were …

Malemedicine.medical_specialtymedicine.medical_treatmentElectric Stimulation TherapyCatheter ablation030204 cardiovascular system & hematologyPulmonary veinlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRecurrencelawInternal medicineAtrial FibrillationClinical endpointHumansMedicine030212 general & internal medicineAtrial tachycardiaAgedbusiness.industryCardiac Pacing ArtificialAtrial fibrillationMiddle AgedAblationmedicine.diseaseSurgeryCatheterTreatment OutcomePulmonary VeinsCatheter AblationCardiologyFemalemedicine.symptombusinessFollow-Up StudiesJACC: Clinical Electrophysiology
researchProduct

Neue Aspekte der elektrischen Defibrillation

1998

In allen internationalen Empfehlungen stellt die schnellstmogliche Defibrillation die Masnahme der Wahl bei Kammerflimmern (VF) und pulsloser ventrikularer Tachykardie (VT) dar. Der Defibrillation kommt eine Schlusselrolle bei der Bekampfung des plotzlichen Herztodes zu. Technische Neuerungen: Entwicklungen auf technischem Gebiet haben einerseits eine weitere Miniaturisierung und Vereinfachung der Gerate, andererseits eine Anpassung der Energiemenge an die individuellen Patientenbedingungen zum Ziel. Implantierbare Kardioverter-Defibrillatoren (ICD) und automatisierte externe Defibrillatoren (AED) basieren auf der gleichen Technologie, einer gerateinternen Analyse des EKG-Signals mit nachfo…

PAROXYSMAL VENTRICULAR TACHYCARDIAGynecologyPublic accessmedicine.medical_specialtyAnesthesiology and Pain MedicineDefibrillationbusiness.industrymedicine.medical_treatmentmedicineGeneral MedicinebusinessDer Anaesthesist
researchProduct

Asymptomatic ventricular pre-excitation in children.

2009

ASYMPTOMATIC VENTRICULAR PREEXCITATION IN CHILDREN OBJECTIVE: This retrospective study was planned for a good risk assessment of asymptomatic patients affected by ventricular pre-excitation. METHODS: From 1985 to 2007, 124 patients with an atrioventricular pathway (electrocardiographic signs of ventricular pre-excitation) were admitted to our cardiology division. The average age was 7 years (range 1 month to 18 years). The mean follow-up period in the whole population of patients was 4.2 years (range 1-13 years). Four patients were lost during the follow-up. During this period, all patients remained in good health. In all of them, we performed a Holter evaluation every year. An intermittent…

PREEXCITATIONmedicine.medical_specialtyTime FactorsAdolescentPopulationAsymptomaticRisk AssessmentPredictive Value of TestsInternal medicinemedicineTachycardia SupraventricularHumanscardiovascular diseasesGood outcomeeducationChildRetrospective Studieseducation.field_of_studybusiness.industryInfantRetrospective cohort studyPre-excitationchildrenGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolarePredictive valueDeath Sudden CardiacChild PreschoolCardiologyElectrocardiography AmbulatoryExercise TestWolff-Parkinson-White SyndromeSupraventricular tachycardiamedicine.symptomCardiology and Cardiovascular MedicineRisk assessmentbusinessElectrophysiologic Techniques CardiacJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Scrotal swelling in a patient with paroxysmal supraventricular tachycardia

2017

We present a case of a patient with paroxysmal supraventricular tachycardia and a history of chronic ischemic disease evolved into dilated cardiomyopathy. During hospitalization, the occurrence of arrhythmic crisis, our patient felt sporadic palpitations associated with dyspnea, distended jugular veins and scrotal swelling, quite unexpected clinical sign that caught our attention. Echocardiography showed dilated left ventricle, severely reduced systolic function, dilated right-sided, dilated inferior vena cava with reduced respiratory excursions. Echography of both testicles showed bilateral expansion of pampiniform plexus with reflux to the functional maneuvers, such as varicocele of grade…

Paroxysmal supraventricular tachycardia Pulmonary hypertension Scrotal swelling Varicocele
researchProduct

Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment

2011

Propafenone is a membrane-stabilizing agent belonging to a subgroup of the Vaughan Williams class I antidysrhythmic agents, structurally resembling propranolol and characterized by weaker beta-blocking activity. Despite respiratory complications having been reported as examples of side effects, very few reports have been published in the literature.We describe the case of an elderly woman with a history of hypertension and allergy to Parietaria, grass, olive, mites, and with periodic asthmatic manifestations, for whom the administration of oral propafenone for recurrent supraventricular dysrhythmia was associated with the sudden onset of severe bronchostenosis.A 78-year-old woman was freque…

Pharmacologybusiness.industryGeneral MedicinePropafenonemedicine.diseaseRhonchipropafenone broncostenosisHypoxemiaBronchospasmAnesthesiamedicineSalbutamolPharmacology (medical)Medical historyRespiratory functionSupraventricular tachycardiamedicine.symptombusinessmedicine.drugAmerican Journal of Therapeutics
researchProduct